AGN - Allergan plc

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 565.85B
Enterprise Value 383.18B
Trailing P/E N/A
Forward P/E 111.07
PEG Ratio (5 yr expected) 13.62
Price/Sales (ttm)4.09
Price/Book (mrq)1.13
Enterprise Value/Revenue 35.17
Enterprise Value/EBITDA 611.12

Trading Information

Stock Price History

Beta (5Y Monthly) 1.69
52-Week Change 345.92%
S&P500 52-Week Change 320.64%
52 Week High 3202.22
52 Week Low 3114.27
50-Day Moving Average 3193.35
200-Day Moving Average 3178.58

Share Statistics

Avg Vol (3 month) 32.37M
Avg Vol (10 day) 32.38M
Shares Outstanding 5328.28M
Float 328.47M
% Held by Insiders 10.25%
% Held by Institutions 197.96%
Shares Short (Jan 30, 2020) 413.7M
Short Ratio (Jan 30, 2020) 45
Short % of Float (Jan 30, 2020) 44.18%
Short % of Shares Outstanding (Jan 30, 2020) 44.17%
Shares Short (prior month Dec 30, 2019) 414.58M

Dividends & Splits

Forward Annual Dividend Rate 42.96
Forward Annual Dividend Yield 41.49%
Trailing Annual Dividend Rate 32.96
Trailing Annual Dividend Yield 31.49%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3Mar 12, 2020
Ex-Dividend Date 4Feb 12, 2020
Last Split Factor 22:1
Last Split Date 3Oct 29, 1997

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Dec 30, 2019

Profitability

Profit Margin -32.76%
Operating Margin (ttm)8.83%

Management Effectiveness

Return on Assets (ttm)0.90%
Return on Equity (ttm)-8.54%

Income Statement

Revenue (ttm)16.09B
Revenue Per Share (ttm)48.90
Quarterly Revenue Growth (yoy)6.60%
Gross Profit (ttm)13.65B
EBITDA 7.48B
Net Income Avi to Common (ttm)-5.27B
Diluted EPS (ttm)-16.02
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.91B
Total Cash Per Share (mrq)17.98
Total Debt (mrq)23.22B
Total Debt/Equity (mrq)39.90
Current Ratio (mrq)1.00
Book Value Per Share (mrq)177.04

Cash Flow Statement

Operating Cash Flow (ttm)7.24B
Levered Free Cash Flow (ttm)7.3B